Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) EPS (Basic) (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed EPS (Basic) for 6 consecutive years, with -$0.02 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 2205.75% to -$0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.07 through Dec 2025, up 554.93% year-over-year, with the annual reading at $0.06 for FY2025, 500.0% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.02 at BioScience Health Innovations, down from -$0.0 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.01 in Q3 2024, with the low at -$0.02 in Q4 2025.
  • Average EPS (Basic) over 5 years is -$0.0, with a median of -$0.0 recorded in 2023.
  • Peak annual rise in EPS (Basic) hit 875.4% in 2025, while the deepest fall reached 2205.75% in 2025.
  • Over 5 years, EPS (Basic) stood at -$0.0 in 2021, then tumbled by 105.25% to -$0.01 in 2022, then soared by 78.53% to -$0.0 in 2023, then soared by 183.57% to $0.0 in 2024, then crashed by 2205.75% to -$0.02 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.02, -$0.0, and $0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.